7-Bromo-4,5-dihydro-1H-pyrido[2,3-e][1,4]diazepin-2(3H)-one, 95.0%, 250mg

1-(4-BROMO-3,5-DIMETHYLPHENYL)-5,5-DIMETHYLIMIDAZOLIDINE-2,4-DIONE, 95%, 5g

(S)-3-(2-METHOXYETHOXY)PYRROLIDINE, 97.0%, 1g

4-Methyl-2-(2-methylphenyl)pentanoic acid, 95%, 5g

4-Chloro-7-methoxy-2-phenylquinoline, 98.0%, 1g

Recipientes de esterilización ROTILABO® para pipetas redondas, 65 mm, longitud exterior, 380 mm 1 pieza

Methyl 2-chloro-6-fluoroquinoline-4-carboxylate, 98%, 1g

6-Chlorobenzothiazol-2-ylamine, 98.0%, 100g

Espátulas dobles de acero inoxidable rígidas, 350 mm, 16 mm, 1 Pieza

(Fmoc-Cys-Otbu)2, 97%, 10g

3-Fluoro-5-nitrobenzoic acid, 95.0%, 1g

Piperazine Dihydrobromide, >98.0%(N)(T), 25g

2-(((1S,2R,4S)-2-((tert-Butoxycarbonyl)amino)-4-(dimethylcarbamoyl)cyclohexyl)amino)-2-oxoacetic acid (Edoxaban Impurity), 97%, 50mg